New Frontiers: Procedures to Tackle Resistant Hypertension

Published: Mar 06, 2024

When medications aren't enough, innovative procedures offer new hope for those battling resistant hypertension. Explore the latest options available.
Contents

Renal Denervation: A Cutting-Edge Therapy

Renal denervation targets nerves in the kidneys to reduce blood pressure. This minimally invasive procedure can be particularly helpful for patients who don't respond well to medications. Several studies have shown its potential in lowering blood pressure, although it's not yet widely available.

Baroreflex Activation Therapy

Baroreflex Activation Therapy involves implanting a device that stimulates the carotid baroreceptors to control blood pressure. Initial trials indicate this therapy can lead to significant blood pressure reductions. However, it's still in the experimental stage and not yet approved in many countries.
Renal denervation is a minimally invasive procedure targeting nerves in the kidneys to reduce blood pressure, offering hope for patients with resistant hypertension.

Considering the Risks and Benefits

While these procedures offer hope, they come with potential risks like nerve injury or fluid retention. Careful evaluation and consultation with healthcare providers are essential. These procedures are usually considered when other treatment options have failed.

Frequently Asked Questions

It's a procedure targeting kidney nerves to lower blood pressure.

It uses a device to stimulate carotid baroreceptors, reducing blood pressure.

Yes, potential risks include nerve injury and fluid retention.

They are still experimental and not approved in all regions.

Innovative Insights

While promising, these procedures should be considered carefully alongside traditional treatments.
Explore advanced treatment options with Doctronic to manage resistant hypertension!

Related Articles

References

  1. Bhatt DL, Vaduganathan M, Kandzari DE, et al. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial. Lancet 2022; 400:1405.
  2. Bisognano JD, Bakris G, Nadim MK, et al. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol 2011; 58:765.

This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.

AI Doctor Visit Required

Appointments available 24/7

😀 😀 😀
stethoscope

Top licensed doctors

Available in all 50 states

dossier

Full service care

Prescriptions, referrals & treatment

check

No insurance needed

All notes available in Doctronic

15-min consultation. No hidden costs.

AI Doctor Visit Required
Close icon

Please Chat With Our AI Doctor First

Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care

Lifebuoy

For safety reasons we have been forced to end this consultation.

If you believe this is a medical emergency please call 911 or your local emergency services immediately.

If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.

Contact us

You can also email us at help@doctronic.ai

We aim to reply within 5-7 days

How likely are you to recommend Doctronic to friends or family?
Not likely at all Extremely likely